scispace - formally typeset
J

James D. Young

Researcher at University of Alberta

Publications -  241
Citations -  16156

James D. Young is an academic researcher from University of Alberta. The author has contributed to research in topics: Nucleoside & Nucleoside transporter. The author has an hindex of 63, co-authored 240 publications receiving 15574 citations. Previous affiliations of James D. Young include Cornell University & Cross Cancer Institute.

Papers
More filters
Journal Article

Characterisation of Amino Acid Transport in Red Blood Cells of a Primitive vertebrate, the Pacific Hagfish (Eptatretus Stouti)

TL;DR: Intracellular amino acid levels and the characteristics of amino acid transport were investigated in red blood cells of a primitive vertebrate, the Pacific hagfish (Eptatretus stouti Lockington).
Journal ArticleDOI

Nitrobenzylthioinosine: an in vivo inhibitor of pig erythrocyte energy metabolism.

TL;DR: The data suggest that pig erythrocytes utilize plasma inosine as their physiological energy substrate, similar to other metabolic energy substrates used by humans.
Journal ArticleDOI

Interactions of Nucleoside Analogs, Caffeine, and Nicotine with Human Concentrative Nucleoside Transporters 1 and 2 Stably Produced in a Transport-Defective Human Cell Line

TL;DR: Although hC NT1 and hCNT2 possess some overlap in transport of several uridine and adenosine analogs, they also exhibit distinct differences in capacity to interact with someAdenosine receptor ligands, adenosines-based drugs, and nicotine.
Journal ArticleDOI

Nucleoside transport in human erythrocytes: nitrobenzylthioinosine binding and uridine transport activities have similar radiation target sizes

TL;DR: The results suggest that the nitrobenzylthioinosine-binding site (s) and the permeation site(s) of the transporter are present on the same transporter element.
Journal ArticleDOI

Uridine Binding and Transportability Determinants of Human Concentrative Nucleoside Transporters

TL;DR: The transportability profiles identified in this study should prove useful in the development of anticancer and antiviral therapies with nucleoside drugs that are permeants of members of the hCNT protein family.